BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3379722)

  • 1. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology.
    Weinstock MA; Horm JW
    JAMA; 1988 Jul; 260(1):42-6. PubMed ID: 3379722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-stage Mycosis Fungoides: Epidemiology and Prognosis.
    Maguire A; Puelles J; Raboisson P; Chavda R; Gabriel S; Thornton S
    Acta Derm Venereol; 2020 Jan; 100(1):adv00013. PubMed ID: 31663598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of mycosis fungoides.
    Weinstock MA
    Semin Dermatol; 1994 Sep; 13(3):154-9. PubMed ID: 7986682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States.
    Weinstock MA; Reynes JF
    Cancer; 1999 Jan; 85(1):208-12. PubMed ID: 9921994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.
    Weinstock MA; Gardstein B
    Am J Public Health; 1999 Aug; 89(8):1240-4. PubMed ID: 10432915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A registry-based case-control study of mycosis fungoides.
    Weinstock MA
    Ann Epidemiol; 1991 Nov; 1(6):533-9. PubMed ID: 1669533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides.
    Weinstock MA; Horm JW
    Cancer; 1988 Oct; 62(8):1658-61. PubMed ID: 3167782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides in Norway 1960-80. A retrospective study.
    McFadden N; Nyfors A; Tanum G; Granholt A; Helme P; Kavli G
    Acta Derm Venereol Suppl (Stockh); 1983; 109():1-13. PubMed ID: 6589937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides.
    Väkevä L; Sarna S; Vaalasti A; Pukkala E; Kariniemi AL; Ranki A
    Acta Derm Venereol; 2005; 85(4):318-23. PubMed ID: 16191852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
    J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of pediatric mycosis fungoides from 2000 to 2017: A national population-based study of the Surveillance, Epidemiology, and End Results database and Texas Cancer Registry.
    Jacob JS; Hunt RD
    J Am Acad Dermatol; 2023 Jan; 88(1):185-187. PubMed ID: 35364212
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycosis fungoides: a retrospective study.
    Redmond WJ; Rahbari H
    J Am Acad Dermatol; 1979 Nov; 1(5):431-6. PubMed ID: 512087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides: epidemiologic observations.
    Greene MH; Dalager NA; Lamberg SI; Argyropoulos CE; Fraumeni JF
    Cancer Treat Rep; 1979 Apr; 63(4):597-606. PubMed ID: 445515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival prediction model for patients with mycosis fungoides/Sezary syndrome.
    Zhu L; Han X; Liu Z; Leng S; Shan N; Lv X; Lu K; Hun S; Wu Y; Liu X
    Future Oncol; 2020 Nov; 16(31):2487-2498. PubMed ID: 32746631
    [No Abstract]   [Full Text] [Related]  

  • 17. Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors.
    Stein M; Farrar N; Jones GW; Wilson LD; Fox L; Wong RK; Kuten A
    Cancer J; 2006; 12(1):55-62. PubMed ID: 16613663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides: an Australian experience.
    Yen A; McMichael A; Kilkenny M; Rotstein H
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S86-90. PubMed ID: 10994481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of mycosis fungoides in patients in the Southeast of England.
    Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
    Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides: review of epidemiological observations.
    Morales Suárez-Varela MM; Llopis González A; Marquina Vila A; Bell J
    Dermatology; 2000; 201(1):21-8. PubMed ID: 10971054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.